Does BELANTAMAB MAFODOTIN-BLMF Cause Condition aggravated? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Condition aggravated have been filed in association with BELANTAMAB MAFODOTIN-BLMF. This represents 6.0% of all adverse event reports for BELANTAMAB MAFODOTIN-BLMF.
9
Reports of Condition aggravated with BELANTAMAB MAFODOTIN-BLMF
6.0%
of all BELANTAMAB MAFODOTIN-BLMF reports
4
Deaths
1
Hospitalizations
How Dangerous Is Condition aggravated From BELANTAMAB MAFODOTIN-BLMF?
Of the 9 reports, 4 (44.4%) resulted in death, 1 (11.1%) required hospitalization.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN-BLMF. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN-BLMF Cause?
Death (32)
Plasma cell myeloma (15)
Keratopathy (11)
Visual impairment (11)
Ocular toxicity (10)
Plasma cell myeloma refractory (9)
Disease progression (7)
Dry eye (7)
Fatigue (7)
Visual acuity reduced (7)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which BELANTAMAB MAFODOTIN-BLMF Alternatives Have Lower Condition aggravated Risk?
BELANTAMAB MAFODOTIN-BLMF vs BELATACEPT
BELANTAMAB MAFODOTIN-BLMF vs BELIMUMAB
BELANTAMAB MAFODOTIN-BLMF vs BELINOSTAT
BELANTAMAB MAFODOTIN-BLMF vs BELUMOSUDIL
BELANTAMAB MAFODOTIN-BLMF vs BELVIQ